DE2533701A1 - Immunologische diagnoseprodukte - Google Patents

Immunologische diagnoseprodukte

Info

Publication number
DE2533701A1
DE2533701A1 DE19752533701 DE2533701A DE2533701A1 DE 2533701 A1 DE2533701 A1 DE 2533701A1 DE 19752533701 DE19752533701 DE 19752533701 DE 2533701 A DE2533701 A DE 2533701A DE 2533701 A1 DE2533701 A1 DE 2533701A1
Authority
DE
Germany
Prior art keywords
agglutination
particles
protein
tetanus
latex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752533701
Other languages
German (de)
English (en)
Inventor
Jun William Frederick Barg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE2533701A1 publication Critical patent/DE2533701A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19752533701 1974-08-01 1975-07-28 Immunologische diagnoseprodukte Withdrawn DE2533701A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49399274A 1974-08-01 1974-08-01

Publications (1)

Publication Number Publication Date
DE2533701A1 true DE2533701A1 (de) 1976-02-12

Family

ID=23962555

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752533701 Withdrawn DE2533701A1 (de) 1974-08-01 1975-07-28 Immunologische diagnoseprodukte

Country Status (10)

Country Link
JP (1) JPS5141422A (da)
AR (1) AR205649A1 (da)
BE (1) BE821053A (da)
BR (1) BR7504611A (da)
CA (1) CA1032470A (da)
DE (1) DE2533701A1 (da)
DK (1) DK349075A (da)
FR (1) FR2280352A1 (da)
GB (1) GB1505400A (da)
ZA (1) ZA754005B (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138297A1 (en) * 1983-09-30 1985-04-24 Becton Dickinson and Company Immuno-agglutination particle suspensions
EP0408078A2 (de) * 1989-07-14 1991-01-16 Roche Diagnostics GmbH Verfahren zur Herstellung einer mit einer immunologisch aktiven Substanz beschichteten Festphasenmatrix

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5819222B2 (ja) * 1977-06-21 1983-04-16 森永乳業株式会社 ステロイド−血清アルブミン複合体感作ラテックス粒子の製造法
JPS6342342Y2 (da) * 1978-04-20 1988-11-07
JPS59224565A (ja) * 1983-04-28 1984-12-17 Morinaga Milk Ind Co Ltd 抗原検出用試薬
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
DE3842700A1 (de) * 1988-12-19 1990-06-21 Boehringer Mannheim Gmbh Verfahren zur proteinimmobilisierung an einer festphase, so hergestellte protein tragende festphase sowie deren verwendung
DE4343479A1 (de) * 1993-12-21 1995-06-22 Boehringer Mannheim Gmbh Acylierte Proteinaggregate und deren Verwendung zur Entstörung von Immunoassays
FR2743891B1 (fr) * 1996-01-18 1998-04-10 Immunotech Sa Procede pour l'identification ou le dosage immunologique d'antigenes polypeptidiques
CN102109521A (zh) * 2010-12-16 2011-06-29 中国环境科学研究院 检测豇豆胰蛋白酶抑制剂的免疫胶乳微球及其制备方法
CN113495139A (zh) * 2021-07-07 2021-10-12 上海清芮科技有限公司 一种宠物特应性体质的检测方法

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138297A1 (en) * 1983-09-30 1985-04-24 Becton Dickinson and Company Immuno-agglutination particle suspensions
EP0408078A2 (de) * 1989-07-14 1991-01-16 Roche Diagnostics GmbH Verfahren zur Herstellung einer mit einer immunologisch aktiven Substanz beschichteten Festphasenmatrix
EP0408078A3 (en) * 1989-07-14 1992-01-29 Boehringer Mannheim Gmbh Method for the preparation of a solid phase coated with an immunologically active substance
US5316784A (en) * 1989-07-14 1994-05-31 Boehringer Mannheim Gmbh Process for the production of a solid phase matrix coated with an immunologically active substance

Also Published As

Publication number Publication date
GB1505400A (en) 1978-03-30
BR7504611A (pt) 1976-08-03
CA1032470A (en) 1978-06-06
AR205649A1 (es) 1976-05-21
ZA754005B (en) 1976-05-26
FR2280352A1 (fr) 1976-02-27
DK349075A (da) 1976-02-02
JPS5141422A (da) 1976-04-07
BE821053A (fr) 1975-04-14

Similar Documents

Publication Publication Date Title
EP0008432B1 (de) Immunologisches Bestimmungsverfahren
DE3884979T2 (de) Agglutinationsimmunotest und Satz zur Bestimmung einer mehrwertigen Immunspezies unter Verwendung einer gepufferten Salzwasch-Lösung.
DE3650513T2 (de) Verzögerter immunologischer Test in fester Phase
EP0305337B1 (de) Verfahren zum Nachweis von Antigenen und/oder Antikörpern sowie Testausrüstung zur Durchführung des Verfahrens
CH627281A5 (da)
DE2164768A1 (de) Verfahren zum Nachweis und zur Bestimmung von spezifischen Bindeproteinen
DE2633877A1 (de) Verfahren zur immunpruefung auf antigene in fester phase
EP0001223A2 (de) Mit einer Polyhydroxyverbindung beschichteten Latex, Verfahren zur Herstellung dieses Latex, immunologisches Reagenz enthaltend diesen Latex, Verfahren zur Herstellung dieses Reagenzes, Verwendung dieses Reagenzes, Bestimmungsverfahren unter Verwendung dieses Reagenzes und Reagenziengarnitur enthaltend dieses Reagenz.
DE69928507T2 (de) Festphasenverfahren und Testkit zur Antigen- und Antikörperbestimmung in der Blutgruppen-Serologie
DE2604844C3 (de) Verfahren zum Nachweis von Hepatitis B-Oberflächenantigen in menschlichem Blut
DE2533701A1 (de) Immunologische diagnoseprodukte
DE2322562A1 (de) Verfahren zur bestimmung eines oder mehrerer antigene in einer probe
CH649306A5 (de) Traegergebundenes immunglobulin-spaltprodukt und seine verwendung fuer immunologische analysenverfahren.
DE3105555C2 (da)
DE3850379T2 (de) Wasser-unlösliches Reagenz, dieses enthaltende Elemente und Verwendungsverfahren.
DE3346795A1 (de) Enzymimmunoassay und entsprechendes diagnostikum
DE69211805T2 (de) Testsatz und Verfahren zum Nachweiss von Mikroorganismen assoziiert mit periodontalen Krankheiten unter Verwendung Surfactantmischung als Extraktionskomposition
DE3889479T2 (de) Mit Nieder-pI-Protein beschichtete Membranstruktur und Verfahren zu ihrer Herstellung und Verwendung.
EP0379216B1 (de) Verfahren und Reagenz zur Bestimmung von immunologisch nachweisbaren Substanzen
EP1386160B1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
DE2850950C3 (de) Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meßreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren
DE3836348A1 (de) Verfahren zur bestimmung von fuer ein antigen klassenspezifischen antikoerpern und dazu geeignetes reagenz
CH645726A5 (de) Praeparat zur bestimmung von menschlichem immunoglobulin g, verfahren zu seiner herstellung und seine verwendung.
DE3883808T2 (de) Testsatz, Extraktionsvorrichtung und Verfahren zur Bestimmung von Streptococcus-A-Antigen.
EP0554657B1 (de) Verfahren zur Bestimmung von Antigenen oder Antikörpern in Gegenwart eines Immunkomplexes

Legal Events

Date Code Title Description
OGA New person/name/address of the applicant
8139 Disposal/non-payment of the annual fee